SMS 2: Impact of Cancer Therapy on the Somatic Mutational Landscape of Normal Tissues

Enrolling by invitationOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

November 26, 2024

Primary Completion Date

May 14, 2028

Study Completion Date

May 13, 2029

Conditions
Somatic MutationCancer
Interventions
OTHER

sample collection

"Participants may collected their own cheek swabs and will collect their own urine samples.~Clinical professionals at participating sites will collect blood samples."

OTHER

Discussing study

Research Nurse/ Suitably qualified Research Site Staff will discuss the study with potential participants

OTHER

Seeking consent

Potential participants who wish to give consent will do with a Research Nurse/ Suitably qualified Research Site Staff.

Trial Locations (1)

Unknown

Wellcome Sanger Institute, Cambridge

All Listed Sponsors
lead

The Wellcome Sanger Institute

OTHER